Key result
Female patients with cardiomyopathy had a significantly lower likelihood of dying at home or in hospice compared to male patients (OR 0.883).
Why the study?
Disparities in place of death can significantly alter end-of-life care for patients with cardiomyopathy, prompting the evaluation of variations based on demographic factors.
Cross-Sectional (n=528,401)
Odds Ratio: 0.883 (95% CI 0.873–0.894)
p-value: p=<0.001
This study highlights significant demographic and regional disparities in the place of death for US cardiomyopathy patients, emphasizing the need for tailored, patient-centered end-of-life care.
Identifies age, gender, and regional disparities in cardiomyopathy place of death; leaves open targeted interventions pending prospective studies.
Background The human experience involves the inevitable end of life, whether sudden or expected. Ensuring a dignified end-of-life encounter necessitates understanding influential factors. Cardiomyopathy, a group of heart muscle diseases, has varying mortality implications, including heart failure and arrhythmias. Disparities in place of death (hospital, home, or hospice) can significantly alter the end-of-life care for a patient. Methods The aim of this study is to identify variations in death locations for U.S. cardiomyopathy patients between 1999 and 2020, based on age, gender, race, and census region, utilizing the CDC WONDER ( CDC Wide-Ranging Online Data for Epidemiologic Research) database, which contains a wide array of public health information. Data were categorized by age, gender, race, and location, and further subcategorized according to place of death. Statistical analysis was done via R programming software. Result The aggregate data of 528,401 cardiomyopathy-related deaths from 1990 to 2020 were obtained. Findings revealed age, gender, and regional disparities in death location. Notably, cardiomyopathy is found to be prevalent in the 75+ years age group, male gender, and people belonging to Caucasian descent, and maximal in the Southern census area. The study's logistic regression analysis unveiled a significant association between demographic factors and death locations. Conclusion This research underscores the significance of understanding disparities in the place of death for cardiomyopathy patients, shedding light on demographic influences and paving the way for patient-centered end-of-life care approaches.
No takes yet. Share an insight, caveat, or question.
Hussein et al. (2023) conducted a cross-sectional in Cardiomyopathy (n=528,401). Female gender vs. Male gender was evaluated on Death at home or hospice (OR 0.883, 95% CI 0.873, 0.894, p=<0.001). Female patients with cardiomyopathy had a significantly lower likelihood of dying at home or in hospice compared to male patients (OR 0.883).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: